![Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions - The Lancet Neurology Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/717c5ac7-14ad-4d09-bc73-1514ace68875/gr1_lrg.jpg)
Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions - The Lancet Neurology
![Molecules | Free Full-Text | In Silico Analysis and In Vitro Characterization of the Bioactive Profile of Three Novel Peptides Identified from 19 kDa α-Zein Sequences of Maize | HTML Molecules | Free Full-Text | In Silico Analysis and In Vitro Characterization of the Bioactive Profile of Three Novel Peptides Identified from 19 kDa α-Zein Sequences of Maize | HTML](https://www.mdpi.com/molecules/molecules-25-05405/article_deploy/html/images/molecules-25-05405-g004.png)
Molecules | Free Full-Text | In Silico Analysis and In Vitro Characterization of the Bioactive Profile of Three Novel Peptides Identified from 19 kDa α-Zein Sequences of Maize | HTML
![Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Diabetes & Endocrinology Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f4fb056d-f07e-42d0-a061-46e94eed729b/gr2_lrg.jpg)